Core Scientific Rides a 45% Revenue Surge Toward Its Two-Year High – But Profits Remain Elusive

Core Scientific shares are changing hands at $23.96, deep in the upper end of their two-year range between $6.63 and $29.16 – a striking climb for a company that emerged from bankruptcy reorganization only a few years ago. This Core Scientific, Inc. stock analysis looks at what’s really driving the move: trailing-twelve-month revenue growth of 44.9% as the company leans into AI-infrastructure and high-performance-computing hosting, set against a five-year revenue CAGR of -20.7% that still reflects its earlier collapse. The gap between those two growth figures is the whole story here.

What Is Happening With the Stock Price

At $23.96, the stock sits roughly 77% of the way up its two-year range ($6.63 low, $29.16 high) – upper-range territory, not the middle or lower band. That positioning suggests the market has already priced in real optimism about Core Scientific’s pivot toward AI and HPC hosting, leaving less room for error if growth or margins disappoint from here.

Quality: Is This a Financially Sound Business?

This Core Scientific, Inc. stock analysis finds profitability is still the weak link, reflected in a Quality Score of just 34/100. Gross margin runs at 21.6%, but operating margin is -18.8% and net margin is 0.0%, with earnings per share of -$3.36 and return on assets of -4.3% (return on equity isn’t meaningful given the loss). Free cash flow is nonetheless positive at $175M on $355M of trailing revenue – a 2.3% FCF yield – a gap that likely reflects heavy non-cash depreciation on data-center assets rather than a fundamentally profitable operation. Liquidity is thin too: a current ratio of 0.55 and quick ratio of 0.38 mean current liabilities outweigh current assets, worth watching through a capital-intensive infrastructure buildout.

Growth: Does This Company Have Real Upside?

Growth Score: 56/100. The 44.9% trailing-twelve-month revenue growth is the headline number, and it’s real evidence that operations are scaling with the AI-infrastructure pivot. But the -20.7% five-year CAGR is a reminder that this revenue base was rebuilt from a much lower point after prior distress – the recent growth rate alone doesn’t confirm the run-rate is durable. Valuation already reflects a lot of that promise: EV/Revenue of 24.41 is a rich multiple for a business with negative operating margin, and EV/EBITDA of -89.51 confirms EBITDA itself is still negative.

Opportunity: Is Now a Good Time to Enter?

Because Core Scientific’s P/E and price-to-book are both not meaningful (no positive earnings, no usable book-value figure), the model doesn’t have enough valuation evidence to score the Opportunity pillar or issue a Buy/Hold/Sell signal here. What the data does show: at 24.41x revenue with EBITDA still negative, the current price already bakes in continued high growth, and the stock’s position near the upper end of its two-year range leaves little valuation cushion if the AI-hosting growth story slows.

Core Scientific, Inc. Stock Analysis: The Bottom Line

This Core Scientific, Inc. stock analysis shows a company in a scale story, not yet a profitability story: 44.9% trailing revenue growth and positive free cash flow of $175M are genuine positives, but an -18.8% operating margin, 0.0% net margin, and sub-1 liquidity ratios show the business isn’t yet self-sustaining on an earnings basis. The model can’t issue a rating here because there’s no usable P/E or P/B to anchor an Opportunity score – investors will need to judge for themselves whether the AI-infrastructure growth trajectory justifies a valuation already trading near two-year highs, with balance-sheet liquidity worth monitoring along the way.